Search results for "POINT"

showing 10 items of 4385 documents

General therapeutic guidelines

2017

There are currently no methods available that have been proven to promote or accelerate regenerative processes in nerves. This lack often leads to disappointment for both patient and physician.

medicine.medical_specialtyDisappointmentDiabetic neuropathyPostherpetic neuralgiabusiness.industryeducationmedicine.diseaseTrigeminal neuralgiahealth services administrationNeuropathic painmedicinemedicine.symptomIntensive care medicinebusinessNorepinephrine reuptake
researchProduct

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance

2021

Introduction Immune checkpoint inhibitors (ICIs) are widely used in the treatment of many cancers as they improve clinical outcomes. However, ICIs have also been associated with the development of immune-related adverse drug reactions (ADRs). Among immune-related ADRs, cardiac immune-related ADRs are rare, but also associated with high mortality rates. Objective The objective of this study was to evaluate the occurrence of cardiac ADRs reported with ICIs in the European spontaneous reporting system. Methods We retrieved individual case safety reports on ICI-induced cardiac ADRs from the website of suspected ADR (www.adrreports.eu) of the European pharmacovigilance database (Eudravigilance).…

medicine.medical_specialtyDurvalumabDrug-Related Side Effects and Adverse ReactionsIpilimumabPembrolizumabToxicology030226 pharmacology & pharmacyPharmacovigilance03 medical and health sciences0302 clinical medicineAtezolizumabInternal medicinePharmacovigilancemedicineHumansPharmacology (medical)Original Research Article030212 general & internal medicineMyocardial infarctionImmune Checkpoint InhibitorsPharmacologybusiness.industryOdds ratiomedicine.diseaseIpilimumabNivolumabNivolumabbusinessmedicine.drugDrug Safety
researchProduct

Electromyographic Activity Evolution of Local Twitch Responses During Dry Needling of Latent Trigger Points in the Gastrocnemius Muscle: A Cross-Sect…

2019

Abstract Objective Trigger points (TrPs) are hypersensitive spots within taut bands of skeletal muscles that elicit referred pain and motor changes. Among the variety of techniques used for treating TrPs, dry needling is one of the most commonly applied interventions. The question of eliciting local twitch responses (LTRs) during TrP dry needling is unclear. Our main aim was to investigate the evolution of the electromyographic (EMG) peak activity of each LTR elicited during dry needling into latent TrPs of the gastrocnemius medialis muscle. Methods Twenty asymptomatic subjects with latent TrPs in the gastrocnemius medialis muscle participated in this cross-sectional study. Changes in EMG s…

medicine.medical_specialtyElectromyographyAsymptomatic03 medical and health sciencesGastrocnemius muscle0302 clinical medicineInternal medicinemedicineHumansMuscle SkeletalMyofascial Pain Syndromes030222 orthopedicsDry needlingReferred painmedicine.diagnostic_testbusiness.industryTrigger PointsGeneral MedicineConfidence intervalData at RestCross-Sectional StudiesAnesthesiology and Pain MedicineDry NeedlingCardiologyNeurology (clinical)Analysis of variancemedicine.symptombusiness030217 neurology & neurosurgeryPain Medicine
researchProduct

Physical therapy in heart failure with preserved ejection fraction: A systematic review.

2014

About 50% of patients with heart failure (HF) have preserved ejection fraction (HFpEF) which is especially common in elderly people with highly prevalent co-morbid conditions. HFpEF is usually defined as an ejection fraction equal to or greater than 50%, although some studies have used a limit as low as 40%. The prevalence of this syndrome is expected to increase over the next decades. The associated impact on mortality and hospital readmissions has made of this entity a major public health issue. Despite the fact that mortality and re-hospitalisation rates of HFpEF are similar to the syndrome of HF with reduced ejection fraction (HFrEF), currently there is no available evidence-based thera…

medicine.medical_specialtyEpidemiologyExercise intoleranceComorbidity030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineQuality of lifeRisk FactorsInternal medicinemedicinePrevalenceElderly peopleHumans030212 general & internal medicineIntensive care medicinePhysical Therapy ModalitiesHeart FailureEjection fractionExercise ToleranceSurrogate endpointbusiness.industryStroke VolumeRecovery of FunctionExercise capacitymedicine.diseaseTreatment OutcomeHeart failureCardiologyQuality of Lifemedicine.symptomCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionEuropean journal of preventive cardiology
researchProduct

Analysis of interobserver variability for endomicroscopy of the gastrointestinal tract

2014

a b s t r a c t Background: Endomicroscopy allows in vivo microscopic investigation of enteral mucosa during endo- scopic examinations. The aim of this study was to determine interobserver variability in the evaluation of endomicroscopic pictures of several organs by groups of investigators composed of confocal experts, pathologists and students. Methods: Twenty-five selected representative endomicroscopic pictures of the colon, stomach and oesophagus (total number, 75) were evaluated based on tissue, inflammatory and neoplastic changes (secondary endpoints). The endomicroscopic presence of neoplastic features was the primary endpoint and correlated with the final histological diagnosis. Re…

medicine.medical_specialtyEsophageal NeoplasmsColonColorectal cancerConcordanceGastroenterologyEsophagusStomach NeoplasmsInternal medicinePathologyClinical endpointmedicineEndomicroscopyHumansEndoscopy Digestive SystemEsophagusObserver VariationMicroscopyGastrointestinal tractMicroscopy ConfocalHepatologybusiness.industryStomachStomachGastroenterologymedicine.diseasemedicine.anatomical_structureColonic NeoplasmsbusinessKappaDigestive and Liver Disease
researchProduct

Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

2018

Background: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients with chronic primary immune thrombocytopenia (ITP). Methods: In this phase III multinational, multicentre, prospective, uncontrolled, open-label, single-arm study, adult patients with a baseline platelet count < 30 × 10 9 /L were treated with IVIG 10% at a dose of 2 g/kg body weight administered over 2 consecutive days. The primary endpoint was Response over the study period and was defined accor…

medicine.medical_specialtyEuropean Medicines Agency guidelinesPlatelet countRenal functionHigh dose030204 cardiovascular system & hematologyGastroenterology03 medical and health sciencesIntravenous immunoglobulin; High dose; Immune thrombocytopenia; Response; European Medicines Agency guidelines; Platelet count; Bleeding assessment; Infusion rate0302 clinical medicineInfusion rateInternal medicinemedicineClinical endpointPlateletAdverse effectIntravenous immunoglobulinbiologybusiness.industryResponseGuidelineImmune thrombocytopeniaImmune thrombocytopenia030220 oncology & carcinogenesisConcomitantbiology.proteinBleeding assessmentOriginal ArticleAntibodybusinessJournal of Hematology
researchProduct

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Mult…

2019

Background Chronic graft-versus-host disease (cGVHD) is the major cause of treatment related morbidity and mortality after allogeneic stem cell transplantation (allo-HSCT). Recently Paul Martin et al. reported that treatment success at 1 year (defined as a patient being in partial (PR) or complete remission (CR) of cGVHD, in ongoing remission of underlying disease and not requiring any secondary treatment for cGVHD) was the only endpoint associated with clinical benefit. Strikingly this robust endpoint was only achieved in less than 20% of patients undergoing primary treatment for cGVHD. Therefore, although most patients show initial response to first-line therapy, long-term clinically mean…

medicine.medical_specialtyEverolimusSurrogate endpointbusiness.industrymedicine.medical_treatmentImmunologyCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologyTransplantationGraft-versus-host diseasePrednisoneInternal medicinemedicinePrednisoloneAdverse effectbusinessmedicine.drugBlood
researchProduct

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents

2016

Abstract Objectives The purpose of this study was to compare the 1-year outcomes of the ABSORB everolimus-eluting bioresorbable scaffold (BRS) (Abbott Vascular, Santa Clara, California) and the XIENCE everolimus-eluting stent (EES) (Abbott Vascular) in patients undergoing percutaneous coronary intervention. Background Randomized studies of the ABSORB BRS have been performed in selected patient and lesion scenarios. The available registries of the ABSORB BRS reflect real-world practice more closely compared with randomized studies, but most of them are limited by the small sample size and the lack of comparative outcomes versus second-generation drug-eluting stents. Methods A total of 1,189 …

medicine.medical_specialtyEverolimusbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionStent030204 cardiovascular system & hematologymedicine.diseaseConfidence interval03 medical and health sciences0302 clinical medicineInternal medicinePropensity score matchingConventional PCIClinical endpointmedicineCardiology030212 general & internal medicineMyocardial infarctionCardiology and Cardiovascular Medicinebusinessmedicine.drugJACC: Cardiovascular Interventions
researchProduct

Basic self-reports as an indicator of physical activity

2016

Introduction: Basic self-reports of physical activity (PA) has been applied by clinicians to identify whether adolescents with asthma are physically active. Aim: To investigate whether basic self-reports of PA in adolescents with and without asthma can be used as an indicator of PA with objective measures as criterion. Methods: One-hundred-and sixty (99 boys) adolescents (mean age 13.5 yrs) with (n=88) and without (n=72) asthma completed recordings of PA for three consecutive week-days and one weekend-day using the SenseWear TM Pro 2 Armband (BodyMedia Inc., Pittsburgh, PA). Cut off point defining moderate to vigorous intensity PA (MVPA) was 3 metabolic equivalents. Self-reported PA was ass…

medicine.medical_specialtyFuture studiesbusiness.industryPhysical activityMean agemedicine.diseaseExplained variationConfidence intervalMetabolic equivalent03 medical and health sciences0302 clinical medicineCut off point030228 respiratory systemmedicinePhysical therapy030212 general & internal medicinebusinesshuman activitiesAsthma7.2 Paediatric Asthma and Allergy
researchProduct

Editorial for the Special Issue “Frontiers in Spectral Imaging and 3D Technologies for Geospatial Solutions”

2019

This Special Issue hosts papers on the integrated use of spectral imaging and 3D technologies in remote sensing, including novel sensors, evolving machine learning technologies for data analysis, and the utilization of these technologies in a variety of geospatial applications. The presented results showed improved results when multimodal data was used in object analysis.

medicine.medical_specialtyGeospatial analysisComputer sciencehyperspectral imagingSciencecomputer.software_genrehyperspectral imaging; point cloud; sensor integration; data fusion; machine learning; deep learning; classification; estimation; semantic segmentation; object detection; point cloud filteringmedicine3D-mallinnussensor integrationpoint cloud filteringdata fusionestimationbusiness.industryDeep learningspektrikuvausQHyperspectral imagingdeep learningobject detectionSensor fusionObject (computer science)Data scienceObject detectionsemantic segmentationSpectral imagingVariety (cybernetics)classificationpoint cloud filteringsegmentointikoneoppiminenmachine learningclassificationGeneral Earth and Planetary SciencesArtificial intelligencekaukokartoitusbusinesscomputerpoint cloudRemote Sensing
researchProduct